Actinium Pharmaceuticals KUV 2024

Mit csinál Actinium Pharmaceuticals?

Actinium Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development of innovative radioactive drugs for the treatment of cancer. The company was founded in 2000 and is headquartered in New York City, USA. Actinium Pharmaceuticals' business model is based on the development and commercialization of therapies for various types of cancer. The company utilizes its expertise in radiochemistry to selectively transport radioactive agents to the tumor and exert their effects. One of Actinium Pharmaceuticals' key focuses is the development of antibody-drug conjugates (ADCs). These are special agents consisting of an antibody and a cytotoxic drug. The antibody specifically targets tumor cells and delivers the drug directly to the tumor. Once there, the drug binds to the cancer cells' DNA and kills them. Another important product of Actinium Pharmaceuticals is the radioimmunotherapeutic drug Iomab-B. This targeted drug has been specifically developed for the treatment of acute myeloid leukemia (AML). Iomab-B is intravenously administered and binds to CD45-positive blood cells, including AML cells. This leads to targeted irradiation and destruction of the cancer cells with radioactive particles. Actinium Pharmaceuticals is also active in the field of clinical diagnostics. The company develops radioactive contrast agents for imaging techniques such as positron emission tomography (PET). These procedures enable more accurate diagnosis of cancer and better treatment planning. Overall, Actinium Pharmaceuticals has a broad portfolio of products and technologies for the treatment of cancer and other diseases. The company collaborates closely with academic partners and other companies to advance its research and development. In recent years, Actinium Pharmaceuticals has achieved important milestones, including FDA approval for its cancer drug Iomab-B in 2019. The company has also obtained numerous patents for its technologies and products. The future prospects for Actinium Pharmaceuticals are promising. The company continues to work on developing innovative therapies for various types of cancer and advancing them into clinical trials. It particularly focuses on rare cancer types and unmet medical needs. Overall, Actinium Pharmaceuticals plays an important role in the field of cancer therapy and radiochemistry. With its broad portfolio of products and technologies, as well as strong partnerships, the company is well-positioned to make significant contributions to the fight against cancer in the future. Actinium Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.